Quest Diagnostics Incorporated

DGX

$180.89

Name : Quest Diagnostics Incorporated

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $20,227,741,696.00

EPSttm : 8.35

Quest Diagnostics Incorporated

$180.89

0.55%

$1.00

Float Short %

3.97

Margin Of Safety %

Put/Call OI Ratio

1.27

EPS Next Q Diff

-0.2

EPS Last/This Y

1.97

EPS This/Next Y

0.57

Price

180.88

Target Price

190.25

Analyst Recom

2.27

Performance Q

5.51

Relative Volume

0.75

Beta

0.59

Ticker: DGX

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-09	DGX	182.75	1.02	0.38	16870
2025-09-10	DGX	180.12	1.01	0.57	16875
2025-09-11	DGX	183.54	1.06	0.14	17305
2025-09-12	DGX	182.89	1.10	0.28	17891
2025-09-15	DGX	180.7	1.10	1.00	17914
2025-09-16	DGX	180.17	1.10	0.26	17924
2025-09-17	DGX	182.25	1.0550143266476	0.63265306122449	17930
2025-09-18	DGX	183.35	1.06	0.27	17943
2025-09-19	DGX	183.55	1.05	5.08	18005
2025-09-22	DGX	184.92	0.94	0.32	11184
2025-09-23	DGX	187	0.93	0.04	11360
2025-09-24	DGX	186.82	0.92	0.59	11433
2025-09-25	DGX	185.5	0.92	3.38	11444
2025-09-26	DGX	188.98	0.92	0.36	11602
2025-09-29	DGX	188.85	0.91	1.67	11739
2025-09-30	DGX	190.57	0.91	1.00	11773
2025-10-01	DGX	181.86	0.98	9.45	12292
2025-10-02	DGX	180.96	1.15	0.83	13554
2025-10-03	DGX	179.49	1.16	12.44	13638
2025-10-06	DGX	178.42	1.24	3.11	14143
2025-10-07	DGX	181.91	1.27	0.56	14309
2025-10-08	DGX	180.94	1.27	2.00	14352
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-09	DGX	182.69	8.8	247.2	9.75
2025-09-10	DGX	180.08	8.8	226.6	9.75
2025-09-11	DGX	183.46	8.8	271.1	9.75
2025-09-12	DGX	182.99	8.8	242.5	9.75
2025-09-15	DGX	180.66	8.8	229.2	9.75
2025-09-16	DGX	180.16	8.8	242.6	9.75
2025-09-17	DGX	182.27	8.8	262.0	9.75
2025-09-18	DGX	183.32	8.8	254.0	9.75
2025-09-19	DGX	183.56	8.8	247.7	9.75
2025-09-22	DGX	184.69	8.8	254.1	9.75
2025-09-23	DGX	187.00	8.8	263.1	9.75
2025-09-24	DGX	186.84	8.8	245.1	9.75
2025-09-25	DGX	185.39	8.8	235.5	9.75
2025-09-26	DGX	188.99	8.8	272.6	9.75
2025-09-29	DGX	188.88	8.8	245.2	9.75
2025-09-30	DGX	190.57	8.8	258.6	9.75
2025-10-01	DGX	181.92	8.8	183.4	9.75
2025-10-02	DGX	180.88	8.8	237.1	9.75
2025-10-03	DGX	179.51	8.8	235.1	9.75
2025-10-06	DGX	178.38	8.8	232.6	9.75
2025-10-07	DGX	181.99	8.8	273.1	9.75
2025-10-08	DGX	180.88	8.8	238.4	9.75
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-09	DGX	-11.70	3.83	3.62
2025-09-10	DGX	-11.70	3.83	3.62
2025-09-11	DGX	-11.70	3.83	3.82
2025-09-12	DGX	-11.70	3.83	3.82
2025-09-15	DGX	-11.70	3.83	3.82
2025-09-16	DGX	-11.70	3.83	3.82
2025-09-17	DGX	-11.70	3.83	3.82
2025-09-18	DGX	-11.70	3.83	3.82
2025-09-19	DGX	-11.70	3.83	3.82
2025-09-22	DGX	-11.04	3.83	3.82
2025-09-23	DGX	-11.04	3.83	3.82
2025-09-24	DGX	-11.04	3.83	3.82
2025-09-25	DGX	-14.97	3.83	3.97
2025-09-26	DGX	-14.97	3.83	3.97
2025-09-29	DGX	-14.97	3.84	3.97
2025-09-30	DGX	-15.00	3.84	3.97
2025-10-01	DGX	-15.00	3.84	3.97
2025-10-02	DGX	-15.00	3.84	3.97
2025-10-03	DGX	-15.00	3.84	3.97
2025-10-06	DGX	-9.11	3.84	3.97
2025-10-07	DGX	-9.11	3.84	3.97
2025-10-08	DGX	-9.11	3.84	3.97
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

2.62

Avg. EPS Est. Current Quarter

2.5

Avg. EPS Est. Next Quarter

2.42

Insider Transactions

-9.11

Institutional Transactions

3.84

Beta

0.59

Average Sales Estimate Current Quarter

2733

Average Sales Estimate Next Quarter

2719

Fair Value

222.19

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

5.5

Max Drawdown 5-Year %

-28.6

Target Price

190.25

P/E

21.63

Forward P/E

17.52

PEG

2.83

P/S

1.92

P/B

2.8

P/Free Cash Flow

16.53

EPS

8.36

Average EPS Est. Cur. Y

9.75

EPS Next Y. (Est.)

10.32

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

8.98

Relative Volume

0.75

Return on Equity vs Sector %

-12.1

Return on Equity vs Industry %

2.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

238.4

Quest Diagnostics Incorporated

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 55000

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

stock quote shares DGX – Quest Diagnostics Incorporated Stock Price stock today

news today DGX – Quest Diagnostics Incorporated stock forecast ,stock prediction 2023 2024 2025

marketwatch DGX – Quest Diagnostics Incorporated yahoo finance google finance

stock history DGX – Quest Diagnostics Incorporated invest stock market

stock prices DGX premarket after hours

ticker DGX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: DGX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y